The humanized Axl antibody-drug conjugate consisting of a pyrrolobenzodiazepine dimer target the protein Axl, of which the overexpression is related with poor prognosis and increased invasiveness of a variety of human cancers such as breast, colon, esophageal carcinoma, osteosarcoma and so on.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-2240z | Mouse Anti-AXL Recombinant Antibody (clone 23F11) | WB, ELISA, IF, IHC | Mouse IgG1 |
HPAB-1616LY | Human Anti-AXL Recombinant Antibody (HPAB-1616LY) | ELISA | Humanized IgG |
HPAB-1617LY | Human Anti-AXL Recombinant Antibody (HPAB-1617LY) | ELISA | Humanized IgG |
HPAB-1618LY | Human Anti-AXL Recombinant Antibody (HPAB-1618LY) | ELISA | Humanized IgG |
HPAB-1619LY | Human Anti-AXL Recombinant Antibody (HPAB-1619LY) | ELISA | Humanized IgG |
There are currently no Customer reviews or questions for TAB-0139CL. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.